Differential expression and distribution of α-, β-, and γ-synuclein in the developing human substantia nigra

被引:74
作者
Galvin, JE [1 ]
Schuck, TM
Lee, VMY
Trojanowski, JQ
机构
[1] Washington Univ, Sch Med, Dept Neurol, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA
[2] Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA
关键词
synuclein; substantia nigra; synaptic proteins; Parkinson's disease; Lewy bodies; neurodegeneration;
D O I
10.1006/exnr.2000.7615
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although the functions of alpha-, beta-, and gamma -synuclein (alphaS, betaS, gammaS, respectively) are unknown, these synaptic proteins are implicated in the pathogenesis of Parkinson's disease (PD) and related disorders. For example, alphaS forms Lewy bodies (LBs) in substantia nigra (SN) neurons of PD. However, since it is not known how these hallmark PD lesions contribute to the degeneration of SN neurons or what the normal function of (YS is in SN neurons, we studied the developing human SN from 11 weeks gestational age (GA) to 16 years of age using immunohistochemistry and antibodies to alphaS, betaS, gammaS, other synaptic proteins, and tyrosine hydoxylase (TH). SN neurons expressed TH at 11 weeks GA and alphaS, betaS, and gammaS appeared initially at 15, 17, and 18 weeks GA, respectively. These synucleins first appeared in perikarya of SN neurons after synaptophysin, but about the same time as synaptotagmin and synaptobrevin. Redistribution of alphaS from perikarya to processes of SN neurons occurred by 18 weeks GA in parallel with synaptophysin, while betaS and synaptotagmin were redistributed similarly between 20 and 28 weeks GA and this also occurred with gammaS and synaptobrevin between 33 weeks GA and 9 months postnatal. These data suggest that (alphaS, betaS, and gammaS may play a functional role in the development and maturation of SN neurons, but it remains to be determined how sequestration of alphaS as LBs in PD contributes to the degeneration of SN neurons, (C) 2001 Academic Press.
引用
收藏
页码:347 / 355
页数:9
相关论文
共 41 条
[1]  
Arnold SE, 1996, J COMP NEUROL, V367, P274, DOI 10.1002/(SICI)1096-9861(19960401)367:2<274::AID-CNE9>3.0.CO
[2]  
2-2
[3]  
Arnold SE, 1996, J COMP NEUROL, V367, P293, DOI 10.1002/(SICI)1096-9861(19960401)367:2<293::AID-CNE10>3.0.CO
[4]  
2-S
[5]  
Aubert I, 1997, J COMP NEUROL, V379, P72, DOI 10.1002/(SICI)1096-9861(19970303)379:1<72::AID-CNE5>3.0.CO
[6]  
2-F
[7]   Neural expression profile of α-synuclein in developing human cortex [J].
Bayer, TA ;
Jäkälä, P ;
Hartmann, T ;
Egensperger, R ;
Buslei, R ;
Falkai, P ;
Beyreuther, K .
NEUROREPORT, 1999, 10 (13) :2799-2803
[8]  
Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.0.CO
[9]  
2-E
[10]   Non-Aβ component of Alzheimer's disease amyloid (NAC) revisited -: NAC and α-synuclein are not associated with Aβ amyloid [J].
Culvenor, JG ;
McLean, CA ;
Cutt, S ;
Campbell, BCV ;
Maher, F ;
Jäkälä, P ;
Hartmann, T ;
Beyreuther, K ;
Masters, CL ;
Li, QX .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) :1173-1181